Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$38.11
+0.4%		$41.31
$18.08
▼
$51.60
$2.12B0.87463,421 shs235,225 shs
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$37.05
0.0%		$39.79
$23.14
▼
$47.02
$1.85B0.11366,221 shs298,953 shs
Progyny, Inc. stock logo
PGNY
Progyny
$25.59
-1.6%		$29.06
$16.10
▼
$33.06
$1.99B1.011.18 million shs911,933 shs
SRTA
Strata Critical Medical
$5.66
-5.2%		$5.50
$3.85
▼
$6.50
$528.15M2.251.06 million shs966,014 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astrana Health, Inc. stock logo
ASTH
Astrana Health
0.00%-3.53%+6.75%+0.53%+18.77%
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
0.00%-1.61%-5.42%-5.45%+41.89%
Progyny, Inc. stock logo
PGNY
Progyny
0.00%+1.36%-16.48%-0.76%+9.84%
SRTA
Strata Critical Medical
0.00%-4.33%+18.92%-2.45%+596,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$38.11
+0.4%		$41.31
$18.08
▼
$51.60
$2.12B0.87463,421 shs235,225 shs
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$37.05
0.0%		$39.79
$23.14
▼
$47.02
$1.85B0.11366,221 shs298,953 shs
Progyny, Inc. stock logo
PGNY
Progyny
$25.59
-1.6%		$29.06
$16.10
▼
$33.06
$1.99B1.011.18 million shs911,933 shs
SRTA
Strata Critical Medical
$5.66
-5.2%		$5.50
$3.85
▼
$6.50
$528.15M2.251.06 million shs966,014 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astrana Health, Inc. stock logo
ASTH
Astrana Health
0.00%-3.53%+6.75%+0.53%+18.77%
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
0.00%-1.61%-5.42%-5.45%+41.89%
Progyny, Inc. stock logo
PGNY
Progyny
0.00%+1.36%-16.48%-0.76%+9.84%
SRTA
Strata Critical Medical
0.00%-4.33%+18.92%-2.45%+596,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Astrana Health, Inc. stock logo
ASTH
Astrana Health
2.78
Moderate Buy$49.4329.70% Upside
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
2.89
Moderate Buy$43.8318.31% Upside
Progyny, Inc. stock logo
PGNY
Progyny
2.85
Moderate Buy$33.9132.51% Upside
SRTA
Strata Critical Medical
2.75
Moderate Buy$8.0041.34% Upside

Current Analyst Ratings Breakdown

Latest SRTA, ASTH, PGNY, and GRDN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
8/21/2026
Progyny, Inc. stock logo
PGNY
Progyny
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$27.00 ➝ $30.00
8/20/2026
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+) ➝ Buy (B-)
8/20/2026
Progyny, Inc. stock logo
PGNY
Progyny
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$37.00
8/20/2026
Progyny, Inc. stock logo
PGNY
Progyny
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$37.00
8/13/2026
Progyny, Inc. stock logo
PGNY
Progyny
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
8/13/2026
Progyny, Inc. stock logo
PGNY
Progyny
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$33.00 ➝ $36.00
8/12/2026
Progyny, Inc. stock logo
PGNY
Progyny
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$34.00 ➝ $30.00
8/10/2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$47.00 ➝ $55.00
8/7/2026
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$43.00 ➝ $49.00
8/7/2026
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$35.00
(Data available from 8/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$3.18B0.67$2.83 per share13.49$14.09 per share2.70
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$1.45B1.27$1.26 per share29.42$3.44 per share10.77
Progyny, Inc. stock logo
PGNY
Progyny
$1.29B1.52$0.72 per share35.32$5.99 per share4.27
SRTA
Strata Critical Medical
$255.98M1.96N/AN/A$3.22 per share1.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$22.49M$0.8246.4821.17N/A1.05%10.30%3.67%11/5/2026 (Estimated)
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$49.22M$1.0335.9727.241.924.50%29.97%16.18%11/9/2026 (Estimated)
Progyny, Inc. stock logo
PGNY
Progyny
$58.52M$0.9227.8218.021.796.00%15.98%10.65%11/5/2026 (Estimated)
SRTA
Strata Critical Medical
$41.35M-$0.04N/AN/AN/A15.71%-2.97%-2.54%N/A

Latest SRTA, ASTH, PGNY, and GRDN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$0.3358$0.80+$0.4642$0.40$985.62 million$972.52 million
8/6/2026Q2 2026
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$0.2617$0.29+$0.0283$0.34$340.45 million$351.77 million
8/6/2026Q2 2026
Progyny, Inc. stock logo
PGNY
Progyny
$0.3348$0.55+$0.2152$0.34$349.05 million$350.51 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Astrana Health, Inc. stock logo
ASTH
Astrana Health
N/AN/AN/AN/AN/A
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
SRTA
Strata Critical Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Astrana Health, Inc. stock logo
ASTH
Astrana Health
1.05
1.23
1.23
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
N/A
1.65
1.33
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.14
2.14
SRTA
Strata Critical Medical
N/A
2.64
2.64

Institutional Ownership

CompanyInstitutional Ownership
Astrana Health, Inc. stock logo
ASTH
Astrana Health
52.77%
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
N/A
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
SRTA
Strata Critical Medical
47.36%

Insider Ownership

CompanyInsider Ownership
Astrana Health, Inc. stock logo
ASTH
Astrana Health
20.30%
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
32.96%
Progyny, Inc. stock logo
PGNY
Progyny
9.90%
SRTA
Strata Critical Medical
15.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Astrana Health, Inc. stock logo
ASTH
Astrana Health
3,00055.74 million44.42 millionOptionable
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
3,60049.80 million33.39 millionN/A
Progyny, Inc. stock logo
PGNY
Progyny
31076.73 million69.13 millionOptionable
SRTA
Strata Critical Medical
13088.47 million74.76 millionN/A

Recent News About These Companies

AWM Investment Company Inc. Makes New $14.87 Million Investment in Strata Critical Medical $SRTA
August 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-awm-investment-company-inc-makes-new-1487-million-investment-in-strata-critical-medical-srta-2026-08-26/
Strata Critical Medical, Inc. (SRTA) Upgraded to Buy: What Does It Mean for the Stock?
August 24, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2979188/strata-critical-medical-inc-srta-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_12_zacks_rank_upgrade-2979188
Does Strata Critical Medical, Inc. (SRTA) Have the Potential to Rally 47.28% as Wall Street Analysts Expect?
August 24, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2978994/does-strata-critical-medical-inc-srta-have-the-potential-to-rally-47-28-as-wall-street-analysts-expect?cid=cs-stocknewsapi-ft-fundamental_analysis|consensus_price_target-2978994
Insider Selling: Strata Critical Medical (NASDAQ:SRTA) Director Sells $29,273.25 in Stock
August 14, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-srta-insider-buying-and-selling-2026-08-14/
Insider Shake-Up at Strata Critical Medical Grabs Investor Attention
August 13, 2026  |  tipranks.comhttps://www.tipranks.com/news/insider-trading/insider-shake-up-at-strata-critical-medical-grabs-investor-attention-insider-trading-news?utm_source=marketbeat.com&utm_medium=referral
Reginald Love Sells 5,091 Shares of Strata Critical Medical (NASDAQ:SRTA) Stock
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/reginald-love-sells-5091-shares-of-strata-critical-medical-nasdaqsrta-stock-2026-08-13/
Strata Critical Medical (SRTA) Q2 2026 Earnings Call Transcript
August 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/strata-critical-medical-srta-q2-173543888.html
Immersion Investment Views Strata Critical Medical (SRTA) as a “Babushka Doll”
August 11, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/immersion-investment-views-strata-critical-medical-srta-as-a-babushka-doll-1809111/
Immersion Investment Views Strata Critical Medical (SRTA) as a “Babushka Doll”
August 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/immersion-investment-views-strata-critical-134404589.html
Dimensional Fund Advisors LP Has $6.76 Million Stock Holdings in Strata Critical Medical $SRTA
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-has-676-million-stock-holdings-in-strata-critical-medical-srta-2026-08-11/
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?
August 6, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2970255/can-strata-critical-medical-inc-srta-run-higher-on-rising-earnings-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_8-2970255
Strata Critical Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4930895-strata-critical-medical-inc-2026-q2-results-earnings-call-presentation
财报电话会议纪要：Strata Critical Medical第二季度营收超预期
August 5, 2026  |  cn.investing.comhttps://cn.investing.com/news/transcripts/article-93CH-3496437
Strata Critical Medical overtreft Q2 2026 omzetverwachting
August 5, 2026  |  nl.investing.comhttps://nl.investing.com/news/transcripts/strata-critical-medical-overtreft-q2-2026-omzetverwachting-93CH-875090
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Strata Critical Medical (SRTA)
August 5, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/SRTA/pressreleases/3637732/analysts-offer-insights-on-healthcare-companies-siemens-healthineers-ag-othersemhf-and-strata-critical-medical-srta/
Strata Critical Medical Q2 Call Signals Clinical Upswing
August 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/strata-critical-medical-q2-call-signals-clinical-upswing?utm_source=marketbeat.com&utm_medium=referral
Strata Critical Medical, Inc. (SRTA) Q2 2026 Earnings Call Transcript
August 4, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4929886-strata-critical-medical-inc-srta-q2-2026-earnings-call-transcript
Wall Street Analysts Predict a 60% Upside in Strata Critical Medical, Inc. (SRTA): Here's What You Should Know
August 4, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2967549/wall-street-analysts-predict-a-60-upside-in-strata-critical-medical-inc-srta-here-s-what-you-should-know?cid=cs-stocknewsapi-ft-fundamental_analysis|consensus_price_target-2967549
Strata Critical Medical (NASDAQ:SRTA) Issues Earnings Results
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/strata-critical-medical-nasdaqsrta-issues-earnings-results-2026-08-04/
Strata Critical Medical Q2 Revenue Rises 60.7% to $72.5 Million
August 4, 2026  |  quiverquant.comQ
Strata Critical Medical Announces Second Quarter 2026 Results
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338160/0/en/strata-critical-medical-announces-second-quarter-2026-results.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Astrana Health stock logo

Astrana Health NASDAQ:ASTH

$38.11 +0.15 (+0.40%)
As of 04:00 PM Eastern

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

Guardian Pharmacy Services stock logo

Guardian Pharmacy Services NYSE:GRDN

$37.05 -0.01 (-0.03%)
As of 03:58 PM Eastern

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

Progyny stock logo

Progyny NASDAQ:PGNY

$25.59 -0.41 (-1.58%)
As of 04:00 PM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Strata Critical Medical NASDAQ:SRTA

$5.66 -0.31 (-5.19%)
As of 04:00 PM Eastern

Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas